Fuzhou Dazi Education Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Fuzhou Dazi Education Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HWYEAMI. The owner is based in Fujian Province.

Room 2210, Building 8, Zone F, Software Park, Gulou District, Fuzhou City

Fujian Province 350000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HWYEAMI
HWYEAMI
Registered 2025

Trademark Classifications

Fuzhou Dazi Education Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Fuzhou Dazi Education Technology Co., Ltd. have?

Fuzhou Dazi Education Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Fuzhou Dazi Education Technology Co., Ltd. file in?

Fuzhou Dazi Education Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Fuzhou Dazi Education Technology Co., Ltd.'s most well-known trademarks?

Fuzhou Dazi Education Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as HWYEAMI. These are among 1 currently registered trademark in the portfolio.

What is Fuzhou Dazi Education Technology Co., Ltd.'s trademark registration success rate?

Fuzhou Dazi Education Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.